5'-amino-5'-deoxy-thymidine | 25152-20-9

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 2 '，5'-二脱氧核苷
• 英文名称: 5'-amino-5'-deoxy-thymidine
• 英文别名: 5'-Amino-5'-deoxythymidin；1-[(2R,5R)-5-(aminomethyl)-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
• CAS: 25152-20-9；108169-96-6
• 化学式: C₁₀H₁₅N₃O₄
• 分子量: 241.247
• InChiKey: PYWLBQPICCQJFF-SPDVFEMOSA-N

物化性质

• 熔点：
  171 - 173°C
• 密度：
  1.394±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  105
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• Antisense molecules and method of controlling expression of gene function by using the same
  申请人：——

  公开号：US20030162739A1

  公开（公告）日：2003-08-28

  An antisense molecule which acts on both directions of the inhibition and expression of a gene function and is capable of on-off switching of a gene function appropriately depending on the external factors (orientation controlling factors); and a method for reversibly controlling the expression of a gene function by using the antisense molecule. Such an antisense molecule, which has at least one sugar-base moiety consisting of sugar and a purine or pyrimidine base bonded thereto via a glucoside bond, can bind to a mRNA/gene and/or dissociate therefrom under the orientation control of the base moiety in the molecule by the orientation controlling factors.

  一种反义分子，可以作用于基因功能的抑制和表达的两个方向，并且能够根据外部因素（定向控制因子）适当地开关基因功能；以及一种通过使用该反义分子可逆地控制基因功能表达的方法。这样的反义分子至少包含一个由糖和通过葡苷键连接到糖上的嘌呤或嘧啶碱基部分，可以通过分子中碱基部分的定向控制因子的定向控制，结合到mRNA/基因上，和/或从中解离。
• Nucleoside derivatives
  申请人：——

  公开号：US20030208050A1

  公开（公告）日：2003-11-06

  Novel nucleoside derivatives represented by the following general formula (1): 1 wherein X is(are) the same or different and each represents a pyrimidine or purine base or a derivative thereof, Y-and Y′ are the same or different and each represents at least one amino acid or amino acid derivative selected from the group consisting of serine, threonine, ornithine, aspartic acid, glutamic acid, lysine, arginine, cysteine, methionine, &dgr;-hydroxylysine, N-aminoethylglycine, N-aminoethylserine, N-aminoethyllysine, N-aminoethylornithine, N-aminoethylaspartic acid, N-aminoethylglutamic acid, homoglutamic acid, &bgr;-thiocarbonylaspartic acid, &ggr;-thiocarbonylglutamic acid, and &dgr;-thiocarbonylhomoglutamic acid, R 1 represents a hydrogen atom or a hydroxyl group, A represents a single bond or a carbonyl or thiocarbonyl group, 1 is an integer of 0 to 5, and n is an integer of 1 to 100.

  以下是通用公式（1）所代表的新型核苷衍生物： 其中X是相同或不同的，每个代表嘧啶或嘌呤碱基或其衍生物，Y和Y'是相同或不同的，每个代表丝氨酸、苏氨酸、鸟氨酸、天冬氨酸、谷氨酸、赖氨酸、精氨酸、半胱氨酸、蛋氨酸、δ-羟基赖氨酸、N-氨基乙基甘氨酸、N-氨基乙基丝氨酸、N-氨基乙基赖氨酸、N-氨基乙基鸟氨酸、N-氨基乙基天冬氨酸、N-氨基乙基谷氨酸、同谷氨酸、β-硫代羰基天冬氨酸、γ-硫代羰基谷氨酸和δ-硫代羰基同谷氨酸，R1代表氢原子或羟基，A代表单键或羰基或硫代羰基，1是0到5的整数，n是1到100的整数。
• [EN] QUINOLINONE DERIVATIVES AS PARP INHIBITORS<br/>[FR] DÉRIVÉS DE QUINOLINONE EN TANT QU'INHIBITEURS DE PARP
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2009053373A1

  公开（公告）日：2009-04-30

  Compounds of formula (I) wherein R1, R2, R3, R4, R5, Z and n have defined meanings, the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary ammonium salts and the stereochemically isomeric forms thereof, and their use for the treatment of PARP- mediated disorders.

  式（I）中R1、R2、R3、R4、R5、Z和n具有定义的含义，其N-氧化物形式，药用可接受的加盐物，季铵盐和立体化学异构体形式，以及它们用于治疗PARP介导的疾病。
• [EN] DERIVATIVES OF PHENYL (THIO) UREA DEOXYTHYMIDINE AND USE THEREOF AS ANTIMALARIALS<br/>[FR] DÉRIVÉS DE PHÉNYL(THIO)URÉEDÉSOXYTHYMIDINE ET LEUR UTILISATION COMME ANTIPALUDIQUES
  申请人：UNIV DUNDEE

  公开号：WO2013014445A1

  公开（公告）日：2013-01-31

  Deoxythymidine derivatives according to formula (I) are disclosed. wherein: X may be O or S; and R1, R2, R3, R4 and R5 may each be independently selected from H, halo, C1-C6 alkyl, C1-C6 haloalkyl, nitro, phenyl, heteroaryl, substituted heteroaryl wherein the substituents may be C1-C6 alkyl or C1-C6 haloalkyl, benzyl, -CH2OAr, -OR6 and six-membered ring heterocyclic groups containing 1 or more O and/or N heteroatoms wherein any N heteroatom may be C1-C6 alkyl-substituted; and R6 may be selected from C1-C6 alkyl, phenyl, six-membered ring heterocyclic groups containing at least one O heteroatom, benzyl and substituted benzyl wherein the substituents may be halo, C1-C6 alkyl or C1-C6 alkoxy; R7 may be H or C1-C6 alkyl; and the stereochemistry of the bond depicted as 〰 is either α or β. Such derivatives have shown good inhibitory activity against malaria-causing parasites, e.g. Plasmodium falciparum, but have shown low levels of toxicity to human cells.

  根据公式（I），披露了脱氧胸苷衍生物。其中：X可以是O或S；R1、R2、R3、R4和R5可以分别独立地选择自H、卤素、C1-C6烷基、C1-C6卤代烷基、硝基、苯基、杂环芳基、取代的杂环芳基，其中取代基可以是C1-C6烷基或C1-C6卤代烷基、苄基、-CH2OAr、-OR6和含有1个或多个O和/或N杂原子的六元环杂环基团，其中任何N杂原子可以是C1-C6烷基取代的；R6可以选择自C1-C6烷基、苯基、含有至少一个O杂原子的六元环杂环基团、苄基和取代的苄基，其中取代基可以是卤素、C1-C6烷基或C1-C6烷氧基；R7可以是H或C1-C6烷基；而所示键的立体化学为α或β。这些衍生物已显示出对引起疟疾的寄生虫，如疟原虫（Plasmodium falciparum），具有良好的抑制活性，但对人类细胞的毒性水平较低。
• [EN] TETRAHYDROPHENANTHRIDINONES AND TETRAHYDROCYCLOPENTAQUINOLINONES AS PARP AND TUBULIN POLYMERIZATION INHIBITORS<br/>[FR] TÉTRAHYDROPHÉNANTHRIDINONES ET TÉTRAHYDROCYCLOPENTAQUINOLINONES COMME INHIBITEURS DE LA POLYMÉRISATION DE LA TUBULINE ET DE PARP
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2009118382A1

  公开（公告）日：2009-10-01

  The present invention provides compounds of formula (I), their use as inhibitors of tubulin polymerization and their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of Formula (I) wherein R1, R2, R3, R 4, R5, R6, R7 and Y have defined meanings.

  本发明提供了式(I)的化合物，其用作微管聚合抑制剂以及用作PARP抑制剂，以及包含所述式(I)化合物的药物组合物，其中R1、R2、R3、R4、R5、R6、R7和Y具有定义的含义。